Eminence Biotechnology

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about
Eminence Biotechnology, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Eminence Biotechnology please access Flcube.com

Company Drug

HUTCHMED Initiates Phase Ia Global Trial of HMPL-A830 – First‑in‑Class KRAS‑Payload Antibody‑Targeted Conjugate Licensed to GSK for up to USD 1.295 Billion

HUTCHMED (China) Limited (NASDAQ: HCM, HKG: 0013) announced that it has initiated the Phase Ia portion of a global clinical trial evaluating HMPL-A830, a potential first‑in‑class antibody‑targeted conjugate (ATTC), for…

September 28, 2026

FDA Approves AbbVie’s Tavapadon as Juvmo for Parkinson’s Disease – Once‑Daily Dopamine Mimetic Joins $8.7 Billion Cerevel Portfolio

September 28, 2026

Biokin Scores Triple NMPA Breakthrough Therapy Designation – BL-M07D1, BL-M05D1, and Iza‑Bren Recognized Across Biliary Tract and Gastric Cancers

September 28, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.

Explore Now

Company